Equities

Fortis Healthcare Ltd

FORTIS:NSI

Fortis Healthcare Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)680.70
  • Today's Change22.60 / 3.43%
  • Shares traded5.48m
  • 1 Year change+83.33%
  • Beta0.8141
Data delayed at least 15 minutes, as of Nov 21 2024 10:26 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Fortis Healthcare Limited is an India-based integrated healthcare delivery service provider. The Company is primarily engaged in the business of healthcare services. The Company operates through healthcare services segment. Its specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, pulmonology, urology, neurosurgery, radiology, orthopedics, and organ transplant, among others. It manages and operates a network of multi-specialty hospitals and diagnostics centers. The healthcare verticals of the Company primarily consist of hospitals, diagnostics, and day care specialty facilities. It has approximately 27 healthcare facilities, including projects under development, 4500 operational beds and over 400 diagnostics centers. It operates in India, United Arab Emirates and Sri Lanka. Its subsidiaries include Escorts Heart Institute and Research Centre Limited, Fortis Health staff Limited, and Fortis Asia Healthcare Pte. Ltd, among others.

  • Revenue in INR (TTM)73.13bn
  • Net income in INR6.56bn
  • Incorporated1996
  • Employees2.59k
  • Location
    Fortis Healthcare LtdTower A, Block - FUnitech Business Park, South City 1Sector - 41GURGAON 122001IndiaIND
  • Phone+91 1 244921021
  • Fax+91 1 244921041
  • Websitehttps://www.fortishealthcare.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Metropolis Healthcare Ltd12.85bn1.48bn103.60bn4.31k70.238.7541.058.0628.7728.77249.83231.050.81856.7210.002,979,279.009.4713.6511.2316.9478.9175.4311.5614.661.4910.320.137623.525.189.67-10.541.2521.84--
Vijaya Diagnostic Centre Ltd6.27bn1.33bn109.69bn2.05k82.7815.1355.5017.4912.9112.9161.0770.640.611414.8354.303,054,368.0013.0014.1014.4015.5487.7985.5821.2621.202.307.540.2866.6619.2913.3640.4020.977.58--
Sagility India Ltd48.61bn2.08bn136.93bn35.86k65.811.8016.282.820.44450.444510.3816.250.4618--4.871,387,054.001.98--2.21--99.00--4.28----2.790.166--12.69--58.99------
Rainbow Children's Medicare Ltd14.25bn2.32bn160.30bn3.94k69.3911.9344.3611.2522.7522.75139.95132.290.68517.9117.843,616,084.0011.179.8912.0410.9687.4582.9616.3113.804.125.020.3602--10.5119.032.9337.2332.22--
Aster DM Healthcare Ltd16.42bn2.51bn215.67bn14.02k89.026.2855.3713.134.86108.0832.2168.980.14671.201.261,171,811.002.852.244.163.6040.8259.7319.404.261.827.410.3501--23.54-14.2212.28-18.156.87--
Krishna Institute Of Medical Sciencs Ltd27.05bn3.31bn226.96bn5.01k68.5311.3443.188.398.288.2867.5950.030.676510.768.265,396,635.009.1013.7111.3316.7379.3754.2913.4515.530.86788.110.43840.0013.6722.17-7.78--52.94--
Dr. Lal PathLabs Ltd23.46bn4.01bn253.36bn4.10k63.1512.6646.1310.8048.1748.17281.60240.300.930610.5526.725,724,423.0016.1315.4920.1219.3880.2876.1317.3315.992.7720.160.088923.8610.4013.1049.7812.436.4431.95
Narayana Hrudayalaya Ltd52.21bn7.79bn256.31bn11.66k32.918.0524.794.9138.3538.35257.10156.860.946620.969.504,477,685.0014.1310.7918.0813.9760.9247.1114.929.721.467.620.34689.6410.9111.8930.1967.8945.2731.95
Fortis Healthcare Ltd73.13bn6.56bn496.61bn2.59k75.776.3346.436.798.688.6896.80103.940.554414.459.8428,202,260.005.343.547.684.5776.4673.049.637.630.43698.570.11978.909.459.051.72--62.52--
Apollo Hospitals Enterprise Limited204.69bn11.83bn961.47bn82.79k81.2612.8250.214.7082.2982.291,423.72521.691.1724.237.292,472,568.006.825.489.377.1348.4148.525.854.821.384.350.482221.9414.7314.669.7130.65--21.67
Max Healthcare Institute Ltd60.08bn10.59bn969.99bn4.05k92.0211.0271.7916.1410.8410.8461.5290.510.505315.0212.5314,846,260.008.916.9810.058.0679.3876.7717.6315.021.2014.690.16733.3418.4926.17-4.16--46.69--
Data as of Nov 21 2024. Currency figures normalised to Fortis Healthcare Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

32.20%Per cent of shares held by top holders
HolderShares% Held
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Oct 202442.86m5.68%
Kotak Mahindra Asset Management Co. Ltd.as of 31 Oct 202439.15m5.19%
Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 31 Mar 202429.69m3.93%
Axis Asset Management Co. Ltd.as of 30 Sep 202424.90m3.30%
Jupiter Asset Management Ltd.as of 31 Jul 202418.85m2.50%
The Vanguard Group, Inc.as of 06 Nov 202418.58m2.46%
SBI Life Insurance Co. Ltd. (Investment Portfolio)as of 31 Mar 202418.34m2.43%
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Oct 202418.03m2.39%
FIL Investment Management (Singapore) Ltd.as of 30 Sep 202417.40m2.31%
Mirae Asset Investment Managers (India) Pvt Ltd.as of 31 Oct 202415.31m2.03%
More ▼
Data from 31 Aug 2024 - 14 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.